DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | - | ₹2.00 Cr | - | - | - |
What is the latest Total Debt ratio of DIVIS LABORATORIES ?
| Year | Total Debt |
|---|---|
| Mar2026 | - |
| Mar2025 | ₹2.00 Cr |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
How is Total Debt of DIVIS LABORATORIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | - | -100.00 | |
| Mar2025 | ₹2.00 Cr | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | - | |
Compare Total Debt of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹266,296.5 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,150.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹112,474.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
| MANKIND PHARMA | ₹102,315.0 Cr | -1.1% | -1.2% | 3.1% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 5% |
7.2% |
49.7% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses